AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Risérus, U.
Right arrow Articles by Vessby, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Risérus, U.
Right arrow Articles by Vessby, B.
Agricola
Right arrow Articles by Risérus, U.
Right arrow Articles by Vessby, B.
American Journal of Clinical Nutrition, Vol. 79, No. 6, 1146S-1148S, June 2004
© 2004 American Society for Clinical Nutrition


THE ROLE OF CONJUGATED LINOLEIC ACID IN HUMAN HEALTH

Metabolic effects of conjugated linoleic acid in humans: the Swedish experience1,2,3,4

Ulf Risérus, Annika Smedman, Samar Basu and Bengt Vessby

1 From the Unit for Clinical Nutrition Research, Department of Public Health and Caring Sciences, University of Uppsala, Uppsala, Sweden

ABSTRACT

Conjugated linoleic acid (CLA) comprises a group of unsaturated fatty acid isomers with a variety of biological effects. CLA reduces body fat accumulation in animal models and has been ascribed significant effects on lipid and glucose metabolism. It has been suggested that the trans-10,cis-12 isomer is the active isomer with regard to antiobesity and insulin-sensitizing properties. The metabolic effects in humans are not well characterized. We have investigated and published the effects of CLA (given as the commercially available mixture and as the purified trans-10,cis-12 isomer) on anthropometry, lipid and glucose metabolism, and markers of lipid peroxidation. The results from those studies indicate that CLA might slightly decrease body fat in humans, particularly abdominal fat, but there is no effect on body weight or body mass index. There is no simultaneous improvement in lipid or glucose metabolism. Rather, the trans-10,cis-12 CLA isomer unexpectedly caused significant impairment of the peripheral insulin sensitivity as well as of blood glucose and serum lipid concentrations. In addition, CLA markedly elevated lipid peroxidation. Thus, the metabolic effects of CLA in humans seem complex, and further studies, especially of specific isomers and of longer duration, are needed.

Key Words: Conjugated linoleic acid • CLA • abdominal obesity • lipid peroxidation • metabolic syndrome




This article has been cited by other articles:


Home page
J. Nutr.Home page
T. Jourdan, L. Djaouti, L. Demizieux, J. Gresti, B. Verges, and P. Degrace
Liver Carbohydrate and Lipid Metabolism of Insulin-Deficient Mice Is Altered by trans-10, cis-12 Conjugated Linoleic Acid
J. Nutr., October 1, 2009; 139(10): 1901 - 1907.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Tholstrup, M. Raff, E. M. Straarup, P. Lund, S. Basu, and J. M. Bruun
An Oil Mixture with Trans-10, Cis-12 Conjugated Linoleic Acid Increases Markers of Inflammation and in Vivo Lipid Peroxidation Compared with Cis-9, Trans-11 Conjugated Linoleic Acid in Postmenopausal Women
J. Nutr., August 1, 2008; 138(8): 1445 - 1451.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. L. Neuhouser, M. J. Barnett, A. R. Kristal, C. B. Ambrosone, I. King, M. Thornquist, and G. Goodman
(n-6) PUFA Increase and Dairy Foods Decrease Prostate Cancer Risk in Heavy Smokers
J. Nutr., July 1, 2007; 137(7): 1821 - 1827.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. A. Bray and F. L. Greenway
Pharmacological Treatment of the Overweight Patient
Pharmacol. Rev., June 1, 2007; 59(2): 151 - 184.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. E. Steck, A. M. Chalecki, P. Miller, J. Conway, G. L. Austin, J. W. Hardin, C. D. Albright, and P. Thuillier
Conjugated Linoleic Acid Supplementation for Twelve Weeks Increases Lean Body Mass in Obese Humans
J. Nutr., May 1, 2007; 137(5): 1188 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Kuhnt, A. Wagner, J. Kraft, S. Basu, and G. Jahreis
Dietary supplementation with 11trans- and 12trans-18:1 and oxidative stress in humans.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 981 - 988.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Poirier, J. S. Shapiro, R. J. Kim, and M. A. Lazar
Nutritional Supplementation With trans-10, cis-12-Conjugated Linoleic Acid Induces Inflammation of White Adipose Tissue
Diabetes, June 1, 2006; 55(6): 1634 - 1641.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Mozaffarian, M. B. Katan, A. Ascherio, M. J. Stampfer, and W. C. Willett
Trans Fatty Acids and Cardiovascular Disease
N. Engl. J. Med., April 13, 2006; 354(15): 1601 - 1613.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. M. Larsen, S. Toubro, O. Gudmundsen, and A. Astrup
Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. C Larsson, L. Bergkvist, and A. Wolk
High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 894 - 900.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition